Clinical Trial Update: Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating bevacizumab with cisplatin, etoposide, and radiation therapy for limited-stage small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CISPLATIN (cisplatin)
• Etoposide (Etoposide)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED